Literature DB >> 24705456

Enhancement of carvedilol solubility by solid dispersion technique using cyclodextrins, water soluble polymers and hydroxyl acid.

K Yuvaraja1, Jasmina Khanam2.   

Abstract

Aim of the present work is to enhance aqueous solubility of carvedilol (CV) by solid dispersion technique using wide variety of carriers such as: β-cyclodextrin (βCD), hydroxypropyl-β-cyclodextrin (HPβCD), tartaric acid (TA), polyvinyl pyrrolidone K-30 (PVP K-30) and poloxamer-407 (PLX-407). Various products of 'CV-solid dispersion' had been studied extensively in various pH conditions to check enhancement of solubility and dissolution characteristics of carvedilol. Any physical change upon interaction between CV and carriers was confirmed by instrumental analysis: XRD, DSC, FTIR and SEM. Negative change of Gibb's free energy and complexation constants (Kc, 75-240M(-1), for cyclodextrins and 1111-20,365M(-1), for PVP K-30 and PLX-407) were the evidence of stable nature of the binding between CV and carriers. 'Solubility enhancement factor' of ionized-CV was found high enough (340 times) with HPβCD in presence of TA. TA increases the binding efficiency of cyclodextrin and changing the pH of microenvironment in dissolution medium. In addition, ionization process was used to increase the apparent intrinsic solubility of drug. In vitro, dissolution time of CV was remarkably reduced in the solid dispersion system compared to that of pure drug. This may be attributed to increased wettability, dispersing ability and transformation of crystalline state of drug to amorphous one.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carvedilol; Cyclodextrin; Dissolution enhancement; Ionization process; Tartaric acid; Water soluble polymer

Mesh:

Substances:

Year:  2014        PMID: 24705456     DOI: 10.1016/j.jpba.2014.03.019

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  10 in total

1.  Pediatric suppositories of sulpiride solid dispersion for treatment of Tourette syndrome: in vitro and in vivo investigations.

Authors:  Ahmed S Zidan; Sherif E Emam; Tamer M Shehata; Fakhr-eldin S Ghazy
Journal:  AAPS PharmSciTech       Date:  2014-12-11       Impact factor: 3.246

2.  pH-Dependent Solubility and Dissolution Behavior of Carvedilol--Case Example of a Weakly Basic BCS Class II Drug.

Authors:  Rania Hamed; Areeg Awadallah; Suhair Sunoqrot; Ola Tarawneh; Sami Nazzal; Tamadur AlBaraghthi; Jihan Al Sayyad; Aiman Abbas
Journal:  AAPS PharmSciTech       Date:  2015-07-23       Impact factor: 3.246

3.  Impact of drying on dissolution behavior of carvedilol-loaded sustained release solid dispersion: development and characterization.

Authors:  Shimul Halder; Fairuza Ahmed; Madhabi Lata Shuma; M A K Azad; Eva Rahman Kabir
Journal:  Heliyon       Date:  2020-09-21

4.  Tablet Formulations of Polymeric Electrospun Fibers for the Controlled Release of Drugs with pH-Dependent Solubility.

Authors:  Valeria Friuli; Silvia Pisani; Bice Conti; Giovanna Bruni; Lauretta Maggi
Journal:  Polymers (Basel)       Date:  2022-05-23       Impact factor: 4.967

5.  Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma.

Authors:  Chandraiah Godugu; Ravi Doddapaneni; Apurva R Patel; Rakesh Singh; Roger Mercer; Mandip Singh
Journal:  Pharm Res       Date:  2015-08-19       Impact factor: 4.200

6.  Preparation and Characterization of a Novel Mucoadhesive Carvedilol Nanosponge: A Promising Platform for Buccal Anti-Hypertensive Delivery.

Authors:  El-Sayed Khafagy; Amr S Abu Lila; Nahed Mohamed Sallam; Rania Abdel-Basset Sanad; Mahgoub Mohamed Ahmed; Mamdouh Mostafa Ghorab; Hadil Faris Alotaibi; Ahmed Alalaiwe; Mohammed F Aldawsari; Saad M Alshahrani; Abdullah Alshetaili; Bjad K Almutairy; Ahmed Al Saqr; Shadeed Gad
Journal:  Gels       Date:  2022-04-11

7.  The Effect of Surfactant Type and Concentration on Physicochemical Properties of Carvedilol Solid Dispersions Prepared by Wet Milling Method.

Authors:  Noushin Bolourchian; Mina Shafiee Panah
Journal:  Iran J Pharm Res       Date:  2022-05-09       Impact factor: 1.962

Review 8.  Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products.

Authors:  Palpandi Pandi; Raviteja Bulusu; Nagavendra Kommineni; Wahid Khan; Mandip Singh
Journal:  Int J Pharm       Date:  2020-06-18       Impact factor: 5.875

9.  Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma.

Authors:  Yi-Dan Chen; Zhong-Yuan Liang; Yan-Yan Cen; He Zhang; Mei-Gui Han; Yun-Qiao Tian; Jie Zhang; Shu-Jun Li; Da-Sheng Yang
Journal:  Drug Des Devel Ther       Date:  2015-11-20       Impact factor: 4.162

10.  Antioxidant MMCC ameliorates catch-up growth related metabolic dysfunction.

Authors:  Liping Ju; Wenxin Tong; Miaoyan Qiu; Weili Shen; Jichao Sun; Sheng Zheng; Ying Chen; Wentao Liu; Jingyan Tian
Journal:  Oncotarget       Date:  2017-10-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.